Angel Studios' faith-based animated film is already racking up the kind of pre-sales that might make its backers nervously start researching the physics of getting camels through the eye of a needle.

The singer, 32, appeared to be in a rage as they endured an intense discussion with their companion beside them. While they were dressed in a white shirt and pinstripe shorts layered under a long ...

President Donald Trump and Secretary of Defense Pete Hegseth deliver remarks in the Oval Office of the White House on March 21, 2025, in Washington, D.C. Anna Moneymaker / Getty Images Speaking to ...

Consumer sentiment in Germany rose slightly in April, compared to the previous month, despite remaining at a low level, according to the latest Consumer Barometer from the German Retail Federation ...

EXCLUSIVE: Hot animation director John Aoshima (Ultraman: Rising) has entered into an exclusive multi-year overall development deal with Bill Damaschke’s Warner Bros. Pictures Animation in ...

Subscribe to our email list for the latest news, information, and commentary from the Berkman Klein Center and our community. Unless otherwise noted this site and its contents are licensed under a ...

Nurix received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount received by Nurix to date to $105 million Nurix is eligible for an ...

Since its founding in 1918, the Commonwealth Fund has been committed to affordable, high-quality health care for everyone. We have worked with all those who share this mission. We believe the health ...

Paramount revealed the new title for their upcoming Last Airbender animated feature film coming ... No footage was shown but the film’s logo was revealed. The Legend of Aang: The Last Airbender ...

Greenyard and Gelagri Bretagne have entered exclusive negotiations to form a strategic partnership in Brittany, France, with the former positioned to become the majority shareholder. A letter of ...

Nurix Therapeutics (NRIX) announced that Sanofi (SNY) has exclusively licensed an undisclosed Nurix program targeting a previously undruggable transcription factor for autoimmune diseases.

The FDA granted Sanofi (SNY) US Services’ rilzabrutinib orphan designation as a treatment of immunoglobulin G4-related disease, according to a post to the agency’s website. Don't Miss Our End ...